Stock DNA
Pharmaceuticals & Biotechnology
CNY 14,359 Million (Large Cap)
85.00
NA
0.76%
-0.20
13.89%
11.79
Revenue and Profits:
Net Sales:
145 Million
(Quarterly Results - Jun 2025)
Net Profit:
35 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
3.92%
0%
3.92%
6 Months
7.53%
0%
7.53%
1 Year
-0.43%
0%
-0.43%
2 Years
-14.75%
0%
-14.75%
3 Years
-15.19%
0%
-15.19%
4 Years
-35.11%
0%
-35.11%
5 Years
94.54%
0%
94.54%
Beijing Balance Medical Technology Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
30.99%
EBIT Growth (5y)
21.12%
EBIT to Interest (avg)
79.77
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.16
Sales to Capital Employed (avg)
0.34
Tax Ratio
12.30%
Dividend Payout Ratio
75.12%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
17.39%
ROE (avg)
8.11%
Valuation key factors
Factor
Value
P/E Ratio
85
Industry P/E
Price to Book Value
11.79
EV to EBIT
84.85
EV to EBITDA
72.41
EV to Capital Employed
14.49
EV to Sales
25.55
PEG Ratio
1.07
Dividend Yield
0.76%
ROCE (Latest)
17.07%
ROE (Latest)
13.89%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
144.90
98.80
46.66%
Operating Profit (PBDIT) excl Other Income
49.40
30.00
64.67%
Interest
0.30
0.10
200.00%
Exceptional Items
-0.50
0.50
-200.00%
Consolidate Net Profit
35.30
30.20
16.89%
Operating Profit Margin (Excl OI)
269.20%
198.70%
7.05%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is 46.66% vs -52.43% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is 16.89% vs -63.22% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
497.70
368.50
35.06%
Operating Profit (PBDIT) excl Other Income
155.90
112.90
38.09%
Interest
0.50
0.50
Exceptional Items
0.70
1.00
-30.00%
Consolidate Net Profit
132.10
109.40
20.75%
Operating Profit Margin (Excl OI)
262.30%
267.60%
-0.53%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 35.06% vs 25.55% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 20.75% vs 15.89% in Dec 2023
About Beijing Balance Medical Technology Co., Ltd. 
Beijing Balance Medical Technology Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






